ClinicalTrials.gg
CompletedNCT07638280Updated Oct 5, 2026

Non-Pharmacological Factors on Spinal Block Duration

An observational study in Paraspinal Muscle Mass and Spinal Anaesthesia, sponsored by Taksim Egitim ve Arastirma Hastanesi. Completed at 1 site in Turkey (Türkiye). Open to participants aged 18 Years to 80 Years. Per ClinicalTrials.gov, last updated 2026-10-05.

Sponsored by Taksim Egitim ve Arastirma Hastanesi · Observational

How we know

Updated Oct 5, 2026Now CompletedPrimary completion moved+2 moreGo to Updates ↓

Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →

Study type
Observational
Model
Cohort
Time perspective
Prospective
Enrollment
108
Ages
18 Years to 80 Years
Sex
All
01

Study summary

The aim of this study is to evaluate the effects of non-pharmacological factors-such as age, sex, body mass index, paraspinal muscle mass, vertebral canal anatomy, patient positioning, and injection technique-on the duration of sensory and motor block in patients undergoing spinal anesthesia, and to investigate the potential relationships between these factors and block duration.

Read the detailed description

It is well known that the level of sensory and motor block following spinal anesthesia varies among individuals. This variability is not only related to the dose of local anesthetic but has also been reported to be associated with patient-related non-pharmacological factors. In particular, a relationship has been demonstrated between body mass index (BMI) and both the level and duration of spinal block, with higher block levels and prolonged block duration observed in patients with increased BMI. This phenomenon is thought to be associated with epidural venous distension due to increased intra-abdominal pressure and a reduction in subarachnoid cerebrospinal fluid (CSF) volume. A decrease in CSF volume may facilitate greater cephalad spread of intrathecal local anesthetic agents, thereby prolonging block duration.

Paraspinal muscle mass is also an important anatomical parameter that may influence intra-abdominal pressure and epidural space compliance, and thus may play a determining role in the spread of spinal anesthesia. However, although several studies have investigated the relationship between BMI and body composition and spinal block characteristics, the number of clinical studies directly evaluating the association between ultrasonographically measured paraspinal muscle mass and spinal anesthesia block duration remains limited. Therefore, ultrasonographic measurement of paraspinal muscle thickness may serve as a potential predictor of spinal block duration.

02

Conditions studied

  • Paraspinal Muscle Mass and Spinal Anaesthesia

Keywords

  • anaesthesia
  • spinal anaesthesia
  • ultrasound
03

In context

Lead sponsor

Taksim Egitim ve Arastirma Hastanesi is the lead sponsor of 10 studies on the registry; 4 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years to 80 Years
Sexes eligible
All
Accepts healthy volunteers
No
Sampling method
Probability sample

Study population

Patients aged 18-80 years, male and female, classified as ASA physical status I-III, and scheduled for elective lower abdominal surgery.

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Patients aged 18-80 years
  • I-III
  • Patients scheduled for elective lower abdominal surgery.

Exclusion criteria

Exclusion Criteria:

  • Patient refusal to participate
  • Coagulopathy
  • Use of medications or substances known to impair coagulation
  • Pregnancy, sepsis
  • Shock
  • Severe aortic or mitral regurgitation
  • Peripheral vascular disease
  • Increased intracranial pressure
  • Mental disorders
  • Spinal column deformity
  • History of previous spinal surgery.
Terms in these criteria, in plain language(1)

Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.

ASA physical status

The anaesthetists’ scale of health before surgery: I is healthy, II has a mild illness that is under control, III a severe one, IV a severe illness that is a constant threat to life. V and VI are used for the critically ill and for organ donors.

05

Study design

Observational model
Cohort
Time perspective
Prospective
Enrollment
108 participants (actual)
Patient registry
No

Interventions

  • Procedurespinal anaesthesia

    Patients who will undergo surgery required spinal anaesthesia

06

What researchers measure

Primary outcomes

  1. Paraspinal mass measurement with ultrasound.

    Ultrasonographic measurement of paraspinal muscle thickness (cm) and its association with duration of spinal block will be investigated.

    Time frame: Pre-operative

Secondary outcomes

  1. The spread of the spinal block

    The speed of the sensational block will be measured after spinal anaesthesia performed. Time(minute) will be recorded when T10 level sensational block is achieved.

    Time frame: Perioperative/Periprocedural

07

Study locations

1 site
  • Taksim Training and Research Hospital
    Istanbul, 34000, Turkey (Türkiye)
08

References and documents

Publications

  • Kahveci M, Ugur L. The Effect of Injection Parameters on Drug Distribution for Spinal Anesthesia: A Numerical Approach. J Clin Med. 2025 Sep 3;14(17):6236. doi: 10.3390/jcm14176236. PubMed 40943995 ↗
  • Paliwal N, Khan IA. Exploring Variability in Spinal Anesthesia Levels Achieved During Cesarean Section Deliveries: A Narrative Review. Cureus. 2025 Jul 21;17(7):e88429. doi: 10.7759/cureus.88429. eCollection 2025 Jul. PubMed 40842780 ↗
  • Belavy DL, Armbrecht G, Felsenberg D. Real-time ultrasound measures of lumbar erector spinae and multifidus: reliability and comparison to magnetic resonance imaging. Physiol Meas. 2015 Nov;36(11):2285-99. doi: 10.1088/0967-3334/36/11/2285. Epub 2015 Oct 9. PubMed 26450474 ↗

Individual participant data

Plan to share: Undecided — All the statistical data will be shared if required

09

Timeline

1 registry update since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reachedDate before it movedWhere the date was before it moved

Ran from Jun 2026 to primary completion in Sep 2026, 3 months.

Since we started tracking on Sep 25, 2026, the dates moved once, on Oct 5, 2026: primary completion Dec 2026 → Sep 2026 and completion Dec 2026 → Sep 2026.

Earlier changes are on the record history on ClinicalTrials.gov ↗

How these figures are worked out, and which studies are left out of them.

Registered
Apr 20, 2026
First posted
Jun 10, 2026
StartActual
Jun 16, 2026
Primary completionActual
Sep 28, 2026was Dec 2026
CompletionActual
Sep 29, 2026was Dec 2026
Last update
Oct 5, 2026
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
Status
Recruiting→Completed
changed Oct 5, 2026
Primary completion
Dec 1, 2026→Sep 28, 2026 (actual)
Oct 5, 2026
Study completion
Dec 16, 2026→Sep 29, 2026 (actual)
Oct 5, 2026
Enrollment
140 (estimated)→108 (actual)
Oct 5, 2026
Show all 1 update
  1. Oct 5, 2026
    Recruiting→Completed
    Primary completion Dec 1, 2026→Sep 28, 2026 (now actual)
    Study completion Dec 16, 2026→Sep 29, 2026 (now actual)
    Enrollment 140 (estimated)→108 (actual)
    + 2 other changes: contact details and site details

From the registry record's own update history. This site started tracking changes on Sep 25, 2026; for anything earlier, see the record history on ClinicalTrials.gov ↗

10

Registry details

Key details

Study ID
NCT07638280
Lead sponsor
Taksim Egitim ve Arastirma Hastanesi
Responsible party
Sponsor
First posted
Jun 10, 2026
Start date
Jun 16, 2026
Primary completion
Sep 28, 2026
Completion
Sep 29, 2026
Last update
Oct 5, 2026

Study contacts

Leyla Sivacigil
principal investigator · Taksim Training and Research Hospital

Oversight

FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Apr 2026. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion